Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Intravenous NA-1 Initiated by Paramedics in the Field for Acute Cerebral Ischemia Within Three Hours of Symptom Onset
NCT02315443 is registered in ClinicalTrials.gov with NoNO Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Intravenous NA-1 Initiated by Paramedics in the Field for Acute Cerebral Ischemia Within Three Hours of Symptom Onset
- Lead sponsor
- NoNO Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 26, 2015
- Completion date
- March 27, 2023
- Enrollment
- 532 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
acute cerebral ischemia